Journal of the Formosan Medical Association
Volume 106, Issue 7 , Pages 513-519, 2007

Seroprevalence of Hepatitis B Viral Markers Among Freshmen — 20 Years After Mass Hepatitis B Vaccination Program in Taiwan

  • Hsien-Cheng Chang

      Affiliations

    • Department of Family Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan
  • ,
  • Chung-Jen Yen

      Affiliations

    • Department of Health Center, Student Affairs Division, National Taiwan University, Taipei, Taiwan
  • ,
  • Yi-Chin Lee

      Affiliations

    • Department of Health Center, Student Affairs Division, National Taiwan University, Taipei, Taiwan
  • ,
  • Tai-Yuan Chiu

      Affiliations

    • Department of Family Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan
  • ,
  • Chyi-Feng Jan

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr Chyi-Feng Jan, Department of Family Medicine, National Taiwan University Hospital, National Taiwan University, 7 Chung-Shan South Road, Taipei 100, Taiwan

Received 11 December 2006; received in revised form 17 January 2007; accepted 13 March 2007.

Article Outline

Background/Purpose

The nationwide hepatitis B vaccination program in Taiwan was well known for its efficacy in reducing the carrier rate of hepatitis B and the morbidity and mortality of hepatitis B-related diseases among children. The aim of this study was to investigate the seroprevalence of hepatitis B 20 years after this program was implemented.

Methods

A total of 7592 freshmen from one university in Northern Taiwan participated in this study during their school entry health exam in September 2003 and September 2004. Basic data including gender, birthday, family history and vaccination history of hepatitis B by self-reported questionnaire were collected. Hepatitis B serum markers, including hepatitis B surface antigen, antibody against hepatitis B surface antigen, and antibody against hepatitis B core antigen were all checked. The differences in the seroprevalence of hepatitis B between two groups of subjects born before July 1984 and after July 1984 were examined. Multiple logistic analyses were performed for identifying the odds ratio (OR) of family history and other variables for each hepatitis B serum marker.

Results

Subjects born after July 1984 were found to have a lower rate of hepatitis B surface antigen of 2.2% (95% confidence interval [CI], 1.8–2.6%) vs. 7.4% (95% CI, 5.9–8.9%), and core antibody against hepatitis B of 6.7% (95% CI, 6.0–7.3%) vs. 23.5% (95% CI, 21.1–25.9%), but a higher rate of surface antibody against hepatitis B of 74.3% (95% CI, 73.2–75.4%) vs. 69.1% (95% CI, 66.5–71.7%) compared with those born before July 1984 (all p < 0.001). Subjects with a family history of hepatitis B had higher risk of being infected by hepatitis B (OR, 4.07; 95% CI, 3.18–5.12) and becoming carriers (OR, 7.26; 95% CI, 5.05–10.44) after adjustment for sex, age, birth year, and self-reported hepatitis B vaccination history.

Conclusion

The seroprevalence of hepatitis B surface antigen continued to decline 20 years after neonatal hepatitis B vaccination program. It is strongly recommended that those who have a family history of hepatitis B should receive early check-up of hepatitis B status after complete vaccination or closely follow up their hepatitis B status after neonatal hepatitis B vaccination.

Key Words:  hepatitis B , seroprevalence , Taiwan , vaccination , youth

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Chen DS , Sung JL . Hepatitis B virus infection in Taiwan . N Engl J Med . 1977;297:668–669
  2. Chen DS , Sung JL , Lai MY . A seroepidemiologic study of hepatitis B virus infection in Taiwan . Taiwan Yi Xue Hui Za Zhi . 1978;77:908–918
  3. Ni YH , Chang MH , Hsu HY , et al.   Hepatocellular carcinoma in childhood. Clinical manifestations and prognosis . Cancer . 1991;68:1737–1741
  4. Beasley RP , Hwang LY , Lin CC , et al.   Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan . Lancet . 1981;2:1129–1133
  5. Chang MH , Chen DS , Hsu HC , et al.   Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma . Cancer . 1989;64:2377–2380
  6. Hsu HM , Chen DS , Chuang CH , et al.   Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers . JAMA . 1988;260:2231–2235
  7. Chen DS , Hsu NH , Sung JL , et al.   A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers . JAMA . 1987;257:2597–2603
  8. Hsu HM , Lu CF , Lee SC , et al.   Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization . J Infect Dis . 1999;179:367–370
  9. Chen HL , Chang MH , Ni YH , et al.   Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan . JAMA . 1996;276:906–908
  10. Chang MH , Chen CJ , Lai MS , et al.   Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group . N Engl J Med . 1997;336:1855–1859
  11. Chen HL , Chang CJ , Kong MS , et al.   Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination . Hepatology . 2004;39:58–63
  12. Kao JH , Hsu HM , Shau WY , et al.   Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan . J Pediatr . 2001;139:349–352
  13. Ni YH , Chang MH , Huang LM , et al.   Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination . Ann Intern Med . 2001;135:796–800
  14. Lin HH , Wang LY , Hu CT , et al.   Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan . J Med Virol . 2003;69:471–474
  15. Lu SN , Chen CH , Chen TM , et al.   Hepatitis B virus infection in adolescents in a rural township–15 years subsequent to mass hepatitis B vaccination in Taiwan . Vaccine . 2005;24:759–765
  16. Chien YC , Jan CF , Kuo HS , et al.   Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched . Epidemiol Rev . 2006;28:126–135
  17. Liu JH , Lu SN , Ho CK , et al.   Changes of hepatitis B markers among young adults in a hepatitis B virus endemic area: a follow up study on medical students . Kaohsiung J Med Sci . 1997;13:286–292
  18. Lok AS , Lai CL . A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children . Hepatology . 1988;8:1130–1133
  19. Fitzsimons D , Francois G , Hall A , et al.   Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants . Vaccine . 2005;23:4158–4166
  20. John TJ , Cooksley G . Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations? . J Gastroenterol Hepatol . 2005;20:5–10
  21. Lu CY , Chiang BL , Chi WK , et al.   Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination . Hepatology . 2004;40:1415–1420
  22. Beasley RP , Hwang LY , Lee GC , et al.   Prevention of perina-tally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine . Lancet . 1983;2:1099–1102
  23. Lo KJ , Tsai YT , Lee SD , et al.   Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers . J Infect Dis . 1985;152:817–822
  24. Lo KJ , Tsai YT , Lee SD , et al.   Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan . Hepatogastroenterology . 1985;32:65–68

PII: S0929-6646(07)60001-1

doi:10.1016/S0929-6646(07)60001-1

Journal of the Formosan Medical Association
Volume 106, Issue 7 , Pages 513-519, 2007